Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BARD1 - Androgen deprivation effect on LNCaP prostate cancer cells: time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BARD1 - Synthetic androgen R1881 effect on transcription factor SRF-deficient prostate cancer cells
BARD1 - ERalpha-negative ERbeta-positive breast carcinoma response to tamoxifen
BARD1 - Androgen receptor antagonist to agonist conversion
BARD1 - Cervical cancer
BARD1 - Cell cycle of T98G glioblastoma cell line
BARD1 - Preimplantation embryonic development (HG-U133_Plus_2)
BARD1 - B-precursor acute lymphoblastic leukemia tumors sensitive and resistant to ionizing radiation
BARD1 - Prostate cancer cell line response to dihydrotestosterone: time course
BARD1 - Erythropoietin effect on early erythroid progenitor cells
BARD1 - Xenograft model of prostate carcinoma progression
BARD1 - Androgen receptor modulator effect: time course (HG-U133B)
BARD1 - Late passage LNCaP prostate tumor cells treated with androgen receptor shRNA or androgen R1881
BARD1 - MicroRNA-135b overexpression effect on prostate cancer cell line: time course
BARD1 - BET bromodomain inhibitor I-BET762 effect on prostate cancer cell lines: dose response
BARD1 - Occupational benzene exposure: peripheral blood mononuclear cells (HumanRef-8)
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on